ADVANCEMENTS IN CLOSED AND AUTOMATED CD34+ HEMATOPOIETIC STEM AND PROGENITOR CELL MANUFACTURING UTILIZING THE MILTENYI CLINIMACS PRODIGY SYSTEM: ENABLING COST-EFFECTIVE NEXT-GENERATION THERAPIES

Autor: Coisman, B., Goldner, K., McCuaig, B., Zhang, M., Bai, T., Jamieson, J., Lucini, C., Ye, L., Goff, N., Kim, J., Qiao, K., Olins, J., Decker, J., Shay, A., Kaur, G., Talukdar, A., Kopesky, P.
Zdroj: In Cytotherapy June 2024 26(6) Supplement:S132-S132
Databáze: ScienceDirect
Externí odkaz: